REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (China)

Main Activities: Scientific Research and Development Services
Full name: Suzhou Zelgen Biopharmaceuticals Co., Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Suzhou Zelgen Biopharmaceuticals Co., Ltd. is mainly engaged in the research and development of innovative chemical and biological drugs in the field of therapeutic such as tumor, blood, liver and gallbladder diseases. The company was founded in 2009 and is headquartered in Kunshan City, China.

Headquarters
No. 209, Chenfeng Road, Yushan Town, Kunshan City, Jiangsu Province
Suzhou; Jiangsu; Postal Code: 215300

Contact Details: Purchase the Suzhou Zelgen Biopharmaceuticals Co., Ltd. report to view the information.

Website: http://www.zelgen.com

Basic Information
Total Employees:
Purchase the Suzhou Zelgen Biopharmaceuticals Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Suzhou Zelgen Biopharmaceuticals Co., Ltd. report to view the information.
Registered Capital:
Purchase the Suzhou Zelgen Biopharmaceuticals Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Suzhou Zelgen Biopharmaceuticals Co., Ltd. report to view the information.
Incorporation Date:
March 18, 2009
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
18.85%
Purchase this report to view the information.
6.23%
Purchase this report to view the information.
4.77%
Purchase this report to view the information.
4.64%
Purchase this report to view the information.
2.62%
Subsidiaries
Shanghai Zejing Pharmaceutical Technology Co., Ltd.
100%
Suzhou Zejing Biotechnology Co., Ltd.
100%
Zejing Holdings Limited
100%
Company Performance
Financial values in the chart are available after Suzhou Zelgen Biopharmaceuticals Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
0.12%▲
Total operating revenue
1.2%▲
Operating profit (EBIT)
24.42%▲
EBITDA
23.14%▲
Net Profit (Loss) for the Period
25.46%▲
Total assets
86.48%▲
Total equity
117.96%▲
Operating Profit Margin (ROS)
13.69%▲
Net Profit Margin
14.15%▲
Return on Equity (ROE)
5.36%▲
Debt to Equity Ratio
-16.42%▼
Quick Ratio
0.72%▲
Cash Ratio
0.76%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo